Moreover, synbiotics have been reported to improve gut integrity via SCFA production, by which inhibiting the TLR4–LPS complex-triggered proinflammatory cascade, hampering proinflammatory cytokine signaling pathways, such as nuclear factor kappa B (NF-κB), thereby decreasing insulin resistance (31, 34). This evidence concerns the gene NFKB1 and Insulin resistance.